These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 27475963)

  • 1. PTEN alterations of the stromal cells characterise an aggressive subpopulation of pancreatic cancer with enhanced metastatic potential.
    Wartenberg M; Centeno I; Haemmig S; Vassella E; Zlobec I; Galván JA; Neuenschwander M; Schlup C; Gloor B; Lugli A; Perren A; Karamitopoulou E
    Eur J Cancer; 2016 Sep; 65():80-90. PubMed ID: 27475963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer.
    Galván JA; Zlobec I; Wartenberg M; Lugli A; Gloor B; Perren A; Karamitopoulou E
    Br J Cancer; 2015 Jun; 112(12):1944-50. PubMed ID: 25989272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN-Dependent Stabilization of MTSS1 Inhibits Metastatic Phenotype in Pancreatic Ductal Adenocarcinoma.
    Zeleniak AE; Huang W; Fishel ML; Hill R
    Neoplasia; 2018 Jan; 20(1):12-24. PubMed ID: 29175021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320.
    Bronisz A; Godlewski J; Wallace JA; Merchant AS; Nowicki MO; Mathsyaraja H; Srinivasan R; Trimboli AJ; Martin CK; Li F; Yu L; Fernandez SA; Pécot T; Rosol TJ; Cory S; Hallett M; Park M; Piper MG; Marsh CB; Yee LD; Jimenez RE; Nuovo G; Lawler SE; Chiocca EA; Leone G; Ostrowski MC
    Nat Cell Biol; 2011 Dec; 14(2):159-67. PubMed ID: 22179046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential.
    Knudsen ES; Balaji U; Freinkman E; McCue P; Witkiewicz AK
    Oncotarget; 2016 Nov; 7(48):78396-78411. PubMed ID: 27623078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
    Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
    Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K/Akt signaling via caveolin-1 and PTEN.
    Xiong J; Wang D; Wei A; Lu H; Tan C; Li A; Tang J; Wang Y; He S; Liu X; Hu W
    Exp Cell Res; 2017 Dec; 361(2):316-323. PubMed ID: 29111166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC.
    Strell C; Norberg KJ; Mezheyeuski A; Schnittert J; Kuninty PR; Moro CF; Paulsson J; Schultz NA; Calatayud D; Löhr JM; Frings O; Verbeke CS; Heuchel RL; Prakash J; Johansen JS; Östman A
    Br J Cancer; 2017 Jun; 117(1):65-77. PubMed ID: 28524160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MTA2-mediated inhibition of PTEN leads to pancreatic ductal adenocarcinoma carcinogenicity.
    Si W; Liu X; Wei R; Zhang Y; Zhao Y; Cui L; Hong T
    Cell Death Dis; 2019 Feb; 10(3):206. PubMed ID: 30814496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin.
    Li CH; To KF; Tong JH; Xiao Z; Xia T; Lai PB; Chow SC; Zhu YX; Chan SL; Marquez VE; Chen Y
    Gastroenterology; 2013 May; 144(5):1086-1097.e9. PubMed ID: 23395645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
    Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
    J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network.
    Ying H; Elpek KG; Vinjamoori A; Zimmerman SM; Chu GC; Yan H; Fletcher-Sananikone E; Zhang H; Liu Y; Wang W; Ren X; Zheng H; Kimmelman AC; Paik JH; Lim C; Perry SR; Jiang S; Malinn B; Protopopov A; Colla S; Xiao Y; Hezel AF; Bardeesy N; Turley SJ; Wang YA; Chin L; Thayer SP; DePinho RA
    Cancer Discov; 2011 Jul; 1(2):158-69. PubMed ID: 21984975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of S100A9 in the interaction between pancreatic ductal adenocarcinoma cells and stromal cells.
    Kung PJ; Lai TY; Cao J; Hsu LC; Chiang TC; Ou-Yang P; Tsai CY; Tsai YF; Lin CW; Chen CC; Tsai MK; Tien YW; Lee CY
    Cancer Immunol Immunother; 2022 Mar; 71(3):705-718. PubMed ID: 34374812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA dysregulation in the tumor microenvironment influences the phenotype of pancreatic cancer.
    Karamitopoulou E; Haemmig S; Baumgartner U; Schlup C; Wartenberg M; Vassella E
    Mod Pathol; 2017 Aug; 30(8):1116-1125. PubMed ID: 28548126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma.
    Askan G; Sahin IH; Chou JF; Yavas A; Capanu M; Iacobuzio-Donahue CA; Basturk O; O'Reilly EM
    BMC Cancer; 2021 Apr; 21(1):385. PubMed ID: 33836674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice.
    Grippo PJ; Fitchev PS; Bentrem DJ; Melstrom LG; Dangi-Garimella S; Krantz SB; Heiferman MJ; Chung C; Adrian K; Cornwell ML; Flesche JB; Rao SM; Talamonti MS; Munshi HG; Crawford SE
    Gut; 2012 Oct; 61(10):1454-64. PubMed ID: 22234980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Concept of Stroma AReactive Invasion Front Areas (SARIFA) as a new prognostic biomarker for lipid-driven cancers holds true in pancreatic ductal adenocarcinoma.
    Grochowski P; Grosser B; Sommer F; Probst A; Waidhauser J; Schenkirsch G; Reitsam NG; Märkl B
    BMC Cancer; 2024 Jun; 24(1):768. PubMed ID: 38926671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The E3 ubiquitin ligase NEDD4 is translationally upregulated and facilitates pancreatic cancer.
    Weng M; Luo ZL; Wu XL; Zeng WZ
    Oncotarget; 2017 Mar; 8(12):20288-20296. PubMed ID: 28423617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-221 Promotes Capan-2 Pancreatic Ductal Adenocarcinoma Cells Proliferation by Targeting PTEN-Akt.
    Yang W; Yang Y; Xia L; Yang Y; Wang F; Song M; Chen X; Liu J; Song Y; Zhao Y; Yang C
    Cell Physiol Biochem; 2016; 38(6):2366-74. PubMed ID: 27230035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.